Authors
Loading...
Simulation explores the effects of response-adaptive randomization with intermediate endpoints in tuberculosis trials, indicating challenges.
Kherabi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: